RT Journal Article
SR Electronic
T1 Risk Factors and Pivotal Periods: Marital Status over 28 Years for Parents of Individuals with Autism
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.28.22271595
DO 10.1101/2022.02.28.22271595
A1 Bahri, Niki
A1 Sterrett, Kyle
A1 Lord, Catherine
YR 2022
UL http://medrxiv.org/content/early/2022/03/01/2022.02.28.22271595.abstract
AB Longitudinal, prospective analyses of marital status in parents of individuals with autism are needed. We describe the timing of divorce, and the factors that contribute to divorce in a longitudinal sample of families of individuals with autism. Participants included parents of 219 children, initially referred for autism and other developmental delays, followed to age 30 years. Approximately 36% of individuals with autism in our sample experienced a parental divorce by age 30. Higher rates of divorce were associated with maternal education, race and age at child’s birth, as well as autism symptom severity and diagnosis. Divorces were most common in early years (under age 5) and also in the teenage years and beyond (over age 15). After age 15, higher risk was associated with higher cognitive ability and daily living skills, and being a multiplex family. Results suggest that divorce risk in families of children with autism remains high through childhood into early adulthood. Understanding factors related to changes in marital status may help us better support families across time.Competing Interest StatementDr. Lord acknowledges the receipt of royalties from the sale of the Autism Diagnostic Observation Schedule (ADOS) and the Autism Diagnostic Interview Revised (ADI R). Royalties generated from this study were donated to a not-for-profit agency, Have Dreams. Dr. Sterrett and Ms. Bahri report no biomedical financial interests or potential conflicts of interest.Funding StatementAll phases of this study were supported by the National Institute of Mental Health R01 MH081873 (PI: C.L.); and the National Institute of Child Health and Human Development R01 HD081199 (PI: C.L.).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of the University of California Los Angeles gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.